Sumatriptan Topical (Zecuity)
Jump to navigation
Jump to search
Indications
Dosage
- iontophoretic transdermal system
Adverse effects
* Zecuity manufacturer Teva Pharmaceuticals has decided to temporarily suspend sales, marketing, & distribution to investigate the cause of burns & scars
More general terms
References
- ↑ 1.0 1.1 FDA Safety alerts. June 2, 2016, June 13, 2106 Zecuity (sumatriptan) Migraine Patch: Drug Safety Communication
FDA Evaluating Risk of Burns and Scars. http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm504736.htm